Lab Automation Global Market Report 2025

Lab automation involves leveraging technology and machinery to streamline and enhance laboratory processes, minimizing manual intervention and boosting efficiency. It encompasses a multi-disciplinary approach aimed at researching, developing, optimizing, and leveraging technologies within the laboratory to enable new and improved processes.

The primary stages in lab automation include the pre-analytical stage, analytical stage, post-analytical stage, and total lab automation. The pre-analytical stage in laboratory medicine refers to the testing phase preceding the actual analysis of a specimen. It encompasses various processes such as discrete processing and continuous flow and finds applications in diagnostics, genomic solutions, microbiology, drug discovery, proteomic solutions, among others. It serves diverse end-users including pharmaceutical and biotechnology companies, research and diagnostic laboratories, among others.

Note that the outlook for this market is being affected by rapid changes in trade relations and tariffs globally. The report will be updated prior to delivery to reflect the latest status, including revised forecasts and quantified impact analysis. The report's Recommendations and Conclusions sections will be updated to give strategies for entities dealing with the fast-moving international environment.

The sharp rise in U.S. tariffs and the resulting trade tensions in spring 2025 are having a notable impact on the services sector, particularly in business services, IT, and professional consulting. The increased costs of imported technology, office equipment, and critical digital infrastructure are driving up operating expenses for service providers, compelling them to either pass these costs on to clients or absorb the financial strain themselves. Outsourcing firms and IT service providers are grappling with higher hardware costs and supply chain delays, which are disrupting project timelines and squeezing profitability. Furthermore, retaliatory tariffs have weakened demand for U.S.-based professional services in key global markets, slowing export-driven revenues. To navigate these challenges, the sector must focus on accelerating digital transformation, optimizing costs, and strengthening domestic client relationships to sustain growth and remain competitive in an increasingly uncertain trade environment.

The lab automation market research report is one of a series of new reports from The Business Research Company that provides lab automation market statistics, including lab automation industry global market size, regional shares, competitors with a lab automation market share, detailed lab automation market segments, market trends and opportunities, and any further data you may need to thrive in the lab automation industry. This lab automation market research report delivers a complete perspective of everything you need, with an in-depth analysis of the current and future scenario of the industry.

The lab automation market size has grown strongly in recent years. It will grow from $7.33 billion in 2024 to $8.03 billion in 2025 at a compound annual growth rate (CAGR) of 9.6%. The growth in the historic period can be attributed to miniaturization of assays and instruments, advancements in robotics and automation technologies, increased demand for high-throughput screening in drug discovery, growth in emphasis on precision and reproducibility in research, and the need for faster and more accurate diagnostic testing.

The lab automation market size is expected to see strong growth in the next few years. It will grow to $11.41 billion in 2029 at a compound annual growth rate (CAGR) of 9.2%. The growth in the forecast period can be attributed to regulatory compliance requirements, demand for remote access and monitoring, labor shortages and skills gap, growing demand for high-throughput screening, and cost reduction pressure. Major trends in the forecast period include integration of artificial intelligence (AI) and machine learning algorithms, expansion of robotic automation, adoption of modular and scalable automation solution, increased use of high-throughput screening technologies, incorporation of advanced imaging and microscopy techniques.

The forecast of 9.2% growth over the next five years reflects a modest reduction of 0.9% from the previous estimate for this market. This reduction is primarily due to the impact of tariffs between the US and other countries. The U.S. could face higher laboratory investment costs as robotic sample handlers, automated liquid systems, and integrated software platforms sourced from Germany and Japan become more expensive to procure. The effect will also be felt more widely due to reciprocal tariffs and the negative effect on the global economy and trade due to increased trade tensions and restrictions.

The increasing demand for personalized medicine is set to drive the growth of the lab automation market in the coming years. Personalized medicine, also referred to as precision medicine, involves tailoring healthcare decisions, interventions, and treatments to individual patients. This demand is rising due to advancements in genomics and molecular diagnostics, greater awareness and education, the growing burden of chronic diseases, and its cost-effectiveness. Lab automation enhances the efficiency, precision, and scalability of laboratory procedures, enabling healthcare professionals and researchers to develop personalized medicine approaches that enhance patient outcomes and optimize treatment effectiveness. For example, as of October 2022, the Personalized Medicine Coalition (PMC) reported that over 75,000 genetic testing products and 300 personalized medicines would be available on the market for various conditions, including multiple types of cancer, genetic rare diseases, and chronic and infectious diseases. Consequently, the increasing demand for personalized medicine is stimulating growth in the lab automation market.

Leading companies in the lab automation market are innovating by creating solutions such as lab automation systems tailored for microbiology laboratories, aiming to optimize laboratory space and streamline workflows. These systems are sophisticated technological solutions designed to enhance the processing, analysis, and management of microbiological samples and data. For instance, in January 2023, Becton, Dickinson, and Company introduced the third-generation BD Kiestra Total Lab Automation System for microbiology laboratories. This modular system is adaptable to meet the specific requirements of laboratories, improving operational efficiency, maximizing budgetary resources, and enhancing laboratory outcomes. Featuring fully automated robotic capabilities, the system streamlines microbiology laboratory processes such as sample processing, digital imaging, incubation, and result analysis. Moreover, its automated microbiology procedures, modular design, scalability, integration with the BD Synapys microbiology informatics solution, and high throughput capabilities are poised to revolutionize clinical bacteriological testing, improve laboratory outcomes, and address the evolving needs of modern microbiology laboratories.

In March 2024, Bruker Corporation acquired Chemspeed Technologies AG to bolster productivity in research and development (R&D) and quality control (QC) departments. This acquisition enables Bruker to offer modular automation solutions that enhance R&D productivity across various industries, including pharmaceuticals, biotech, chemicals, materials, cosmetics, and food. Chemspeed Technologies AG specializes in providing high-throughput and high-output research and development and quality control workflow solutions, making it a valuable addition to Bruker's portfolio.

Major companies operating in the lab automation market report are Thermo Fisher Scientific; Becton Dickinson And Company (BD); Agilent Technologies Inc.; PerkinElmer LLC; Beckman Coulter Inc.; Biomek Inc.; Bio-Rad Laboratories; QIAGEN N.V.; Tecan Group; Brooks Life Sciences; Hamilton Company; Promega Corporation; Opentrons Labworks Inc; Analytik Jena AG; Gilson Inc.; Eppendorf Corporate; Hudson Robotics; Cartesian Therapeutics; Labcyte Inc. (now part of Beckman Coulter Life Sciences); Zymo Research Corp.; Perceptive Instruments Ltd.; Synthace Ltd.; Festo Corp.; Roche Diagnostics; Peak Analysis & Automation (PAA)

North America was the largest region in the lab automation market in 2024. Asia-Pacific is expected to be the fastest-growing region in the forecast period. The regions covered in the lab automation market report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East, Africa.

The countries covered in the lab automation market report are Australia, Brazil, China, France, Germany, India, Indonesia, Japan, Russia, South Korea, UK, USA, Canada, Italy, Spain.

The lab automation market includes revenues earned by entities by providing services such as workflow analysis and optimization, system integration, custom software development, instrument maintenance and support, and training. The market value includes the value of related goods sold by the service provider or included within the service offering. Only goods and services traded between entities or sold to end consumers are included.

The market value is defined as the revenues that enterprises gain from the sale of goods and/or services within the specified market and geography through sales, grants, or donations in terms of the currency (in USD, unless otherwise specified).

The revenues for a specified geography are consumption values that are revenues generated by organizations in the specified geography within the market, irrespective of where they are produced. It does not include revenues from resales along the supply chain, either further along the supply chain or as part of other products.

Lab Automation Global Market Report 2025 from The Business Research Company provides strategists, marketers and senior management with the critical information they need to assess the market.

This report focuses on lab automation market which is experiencing strong growth. The report gives a guide to the trends which will be shaping the market over the next ten years and beyond.

Reasons to Purchase

• Gain a truly global perspective with the most comprehensive report available on this market covering 15 geographies.
• Assess the impact of key macro factors such as geopolitical conflicts, trade policies and tariffs, post-pandemic supply chain realignment, inflation and interest rate fluctuations, and evolving regulatory landscapes.
• Create regional and country strategies on the basis of local data and analysis.
• Identify growth segments for investment.
• Outperform competitors using forecast data and the drivers and trends shaping the market.
• Understand customers based on the latest market shares.
• Benchmark performance against key competitors.
• Suitable for supporting your internal and external presentations with reliable high quality data and analysis
• Report will be updated with the latest data and delivered to you within 2-3 working days of order along with an Excel data sheet for easy data extraction and analysis.
• All data from the report will also be delivered in an excel dashboard format.

Where is the largest and fastest growing market for lab automation ? How does the market relate to the overall economy, demography and other similar markets? What forces will shape the market going forward, including technological disruption, regulatory shifts, and changing consumer preferences? The lab automation market global report from the Business Research Company answers all these questions and many more.

The report covers market characteristics, size and growth, segmentation, regional and country breakdowns, competitive landscape, market shares, trends and strategies for this market. It traces the market's historic and forecast market growth by geography.

• The market characteristics section of the report defines and explains the market.
• The market size section gives the market size ($b) covering both the historic growth of the market, and forecasting its development.
• The forecasts are made after considering the major factors currently impacting the market. These include:

The forecasts are made after considering the major factors currently impacting the market. These include the technological advancements such as AI and automation, Russia-Ukraine war, trade tariffs (government-imposed import/export duties), elevated inflation and interest rates.

• Market segmentations break down the market into sub markets.
• The regional and country breakdowns section gives an analysis of the market in each geography and the size of the market by geography and compares their historic and forecast growth.
• The competitive landscape chapter gives a description of the competitive nature of the market, market shares, and a description of the leading companies. Key financial deals which have shaped the market in recent years are identified.
• The trends and strategies section analyses the shape of the market as it emerges from the crisis and suggests how companies can grow as the market recovers.

Scope

• Markets Covered:1) By Stage Of Automation: Pre-Analytical Stage; Analytical Stage; Post-Analytical Stage; Total Lab Automation
• 2) By Process: Discrete Processing; Continuous Flow
• 3) By Application: Diagnostics; Genomic Solutions; Microbiology; Drug Discovery; Proteomic Solutions; Other Applications
• 4) By End-User: Pharmaceutical and Biotechnology Companies; Research and Diagnostic Laboratories; Other End-Users
• Subsegments:
• 1) By Pre-Analytical Stage: Sample Collection; Sample Preparation; Sample Storage
• 2) By Analytical Stage: Sample Analysis; Data Collection; Testing & Measurement
• 3) By Post-Analytical Stage: Data Interpretation; Reporting Results; Quality Control
• 4) By Total Lab Automation: End-To-End Automation Of Lab Processes; Integration Of Pre, Analytical, And Post-Analytical Stages
• Companies Mentioned:Thermo Fisher Scientific; Becton Dickinson And Company (BD); Agilent Technologies Inc.; PerkinElmer LLC; Beckman Coulter Inc.; Biomek Inc.; Bio-Rad Laboratories; QIAGEN N.V.; Tecan Group; Brooks Life Sciences; Hamilton Company; Promega Corporation; Opentrons Labworks Inc; Analytik Jena AG; Gilson Inc.; Eppendorf Corporate; Hudson Robotics; Cartesian Therapeutics; Labcyte Inc. (now part of Beckman Coulter Life Sciences); Zymo Research Corp.; Perceptive Instruments Ltd.; Synthace Ltd.; Festo Corp.; Roche Diagnostics; Peak Analysis & Automation (PAA)
• Countries: Australia; Brazil; China; France; Germany; India; Indonesia; Japan; Russia; South Korea; UK; USA; Canada; Italy; Spain
• Regions: Asia-Pacific; Western Europe; Eastern Europe; North America; South America; Middle East; Africa
• Time Series: Five years historic and ten years forecast.
• Data: Ratios of market size and growth to related markets, GDP proportions, expenditure per capita,
• Data Segmentations: country and regional historic and forecast data, market share of competitors, market segments.
• Sourcing and Referencing: Data and analysis throughout the report is sourced using end notes.
• Delivery Format: PDF, Word and Excel Data Dashboard.